HWAM
KRYS icon

Hennion & Walsh Asset Management’s Krystal Biotech KRYS Stock Holding History

Hennion & Walsh Asset Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$496K Buy
1,491
+585
+65% +$203K 0.01% 749
2026
Q2 		$337K Buy
+906
New +$271K 0.01% 833
2025
Q3 		– Sell
-3,253
Closed -$447K – 959
2025
Q2 		$447K Sell
3,253
-6,952
-68% -$1.02M 0.02% 707
2025
Q1 		$1.84M Sell
10,205
-3,473
-25% -$584K 0.08% 295
2024
Q4 		$2.14M Sell
13,678
-232
-2% -$41.2K 0.1% 272
2024
Q3 		$2.53M Sell
13,910
-7,740
-36% -$1.49M 0.12% 220
2024
Q2 		$3.98M Sell
21,650
-11,504
-35% -$1.93M 0.2% 117
2024
Q1 		$5.9M Buy
33,154
+1,756
+6% +$244K 0.32% 62
2023
Q4 		$3.9M Sell
31,398
-19,423
-38% -$2.15M 0.22% 110
2023
Q3 		$5.9M Buy
50,821
+1,139
+2% +$139K 0.38% 45
2023
Q2 		$5.83M Buy
49,682
+4,447
+10% +$454K 0.35% 62
2023
Q1 		$3.62M Buy
45,235
+32
+0.1% +$2.51K 0.22% 118
2022
Q4 		$3.58M Buy
45,203
+4,547
+11% +$337K 0.22% 116
2022
Q3 		$2.83M Buy
40,656
+7,663
+23% +$554K 0.19% 144
2022
Q2 		$2.17M Buy
32,993
+9,625
+41% +$599K 0.13% 191
2022
Q1 		$1.55M Buy
23,368
+9,231
+65% +$576K 0.08% 257
2021
Q4 		$989K Buy
+14,137
New +$823K 0.05% 360

Other funds holding KRYS

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $251M AUM 42.58% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return
TNAM
Terra Nova Asset Management New York $155M AUM 33.52% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Hennion & Walsh Asset Management's KRYS Position: Q3 2026 in Review

Hennion & Walsh Asset Management increased its Krystal Biotech (KRYS) stake by 65% in Q3 2026, buying an estimated $203K and bringing the position to 1,491 shares worth $496K. The position accounts for 0.01% of the portfolio, ranked #749.

Hennion & Walsh Asset Management first reported a position in KRYS in Q4 2021 and has held it in 17 quarters since. The position peaked at $5.9M in Q1 2024. 26 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Hennion & Walsh Asset Management held 1,491 shares of Krystal Biotech worth $496K as of Q3 2026.
  • Hennion & Walsh Asset Management bought 585 Krystal Biotech shares in Q3 2026, an estimated $203K.
  • Krystal Biotech made up 0.01% of Hennion & Walsh Asset Management's portfolio in Q3 2026, its #749 holding.
  • Hennion & Walsh Asset Management first reported a position in Krystal Biotech in Q4 2021 and has held it in 17 quarters since.
  • Hennion & Walsh Asset Management's Krystal Biotech position peaked at $5.9M in Q1 2024.
  • 26 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.